欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号HU/V/0120/001
药品名称Coglapix
活性成分
    • actinobacillus pleuropneumoniae 16.7 U/ml
剂型Suspension for injection
上市许可持有人CEVA.Phylaxia Co. Ltd.
参考成员国 - 产品名称Hungary (HU)
Coglapix
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
      Coglapix
    • Netherlands (NL)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
      Coglapix suspension for injection
    • Austria (AT)
      Coglapix Injektionssuspension für Schweine
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Coglapix
    • Lithuania (LT)
    • Estonia (EE)
      Coglapix
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
      Coglapix injekční suspenze pro prasata
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2015/08/28
最近更新日期2024/06/10
药物ATC编码
    • QI09AB07 actinobacillus/haemophilus vaccine
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase